Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

FDA advisory committee recommends approval of capecitabine

March 23, 1998

Cellomics receives funding for novel anticancer agent screens

March 23, 1998

Introgen granted option for tumor suppressor gene

March 20, 1998

Approval recommended for Gemzar supplemental NDA

March 20, 1998

New antineoplastic glutamic acid derivatives synthesized at Princeton

March 20, 1998

Mechanism of chemopreventive activity of resveratrol identified

March 19, 1998

Anticancer drug discovery collaboration initiated by Tripos, MDS Panlabs and Cell Pathways

March 18, 1998

Verapamil analogues reverse MDR in cancer cells

March 18, 1998

Isis reports incident of data manipulation; clinical progress will not be affected

March 17, 1998

Third phase II trial begins of ONYX-015 in head and neck cancer

March 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...